Scholarlink

<p>Addressing whether antisense oligonucleotides (ASOs)-based targeting of genes embedded with intronic noncoding RNAs (ncRNAs) affects the expression and function of intronic ncRNAs is crucial to the success of ASOs in clinical trials.&#xa0;While studying zebrafish posterior pituitary development—an important neuroendocrine interface—we found that an ASO targeting the <i>slit3</i> splice site, but not the translation start site, disrupts pituitary axonal morphogenesis.&#xa0;In addition to altered <i>slit3</i> splicing, we observed increased expression of <i>slit3</i>, its intron-embedded microRNA <i>mir-218a-1</i>, its longest intron, and the paralogous <i>slit2</i> gene. The ASO-induced phenotype does not occur when mature <i>mir-218a-1</i> is blocked by an ASO or in <i>mir-218a-1</i><sup><i>−/−</i></sup> mutants, or when the splicing of the exon immediately upstream of the <i>mir-218a-1</i> embedded intron is blocked by an ASO. The axonal phenotype also phenocopies in samples injected with <i>mir-218a</i> mimic in a dose-dependent manner. Our results indicate that despite the ASO-induced genetic compensation response, intron-retained transcripts can escape the nonsense-mediated decay (NMD) machinery, become stabilized, and lead to increased intronic primary microRNA expression and function. As prematurely terminated intron-retained transcripts can translocate to axons and affect neuronal function, our study warrants further validation for other classes of ncRNAs. Moreover, the idiosyncratic phenotypes observed with translation- versus splice-blocking ASOs can serve as markers to identify the role of intronic microRNAs.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Targeted blocking of gene splicing can dysregulate intron-embedded primary microRNAs

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月16日

查看全文
  • Md Hasan Ali,
  • Athul R. Ramesh,
  • Naveen Nedunchezhian,
  • Wojciech Kwiatkowski,
  • Piotr Kopeć,
  • Natalia Kowalewska,
  • Sebastian Pęcherz,
  • Barbara Gnutti,
  • Dario Finazzi,
  • Savani Anbalagan

摘要

Addressing whether antisense oligonucleotides (ASOs)-based targeting of genes embedded with intronic noncoding RNAs (ncRNAs) affects the expression and function of intronic ncRNAs is crucial to the success of ASOs in clinical trials. While studying zebrafish posterior pituitary development—an important neuroendocrine interface—we found that an ASO targeting the slit3 splice site, but not the translation start site, disrupts pituitary axonal morphogenesis. In addition to altered slit3 splicing, we observed increased expression of slit3, its intron-embedded microRNA mir-218a-1, its longest intron, and the paralogous slit2 gene. The ASO-induced phenotype does not occur when mature mir-218a-1 is blocked by an ASO or in mir-218a-1−/− mutants, or when the splicing of the exon immediately upstream of the mir-218a-1 embedded intron is blocked by an ASO. The axonal phenotype also phenocopies in samples injected with mir-218a mimic in a dose-dependent manner. Our results indicate that despite the ASO-induced genetic compensation response, intron-retained transcripts can escape the nonsense-mediated decay (NMD) machinery, become stabilized, and lead to increased intronic primary microRNA expression and function. As prematurely terminated intron-retained transcripts can translocate to axons and affect neuronal function, our study warrants further validation for other classes of ncRNAs. Moreover, the idiosyncratic phenotypes observed with translation- versus splice-blocking ASOs can serve as markers to identify the role of intronic microRNAs.